Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Glaucoma Patch Graft Surgery Utilizing Corneas Augmented with Collagen Cross-linking.

Stone DU, Craven ER, Ahmad SI, AlBeshri A, Owaidhah OA.

Middle East Afr J Ophthalmol. 2019 Sep 30;26(3):148-152. doi: 10.4103/meajo.MEAJO_78_18. eCollection 2019 Jul-Sep.

PMID:
31619902
2.

Retinal Detachment After Cyclophotocoagulation in a Child with Knobloch Syndrome.

Al-Beshri AS, Kozak I, Craven ER.

Middle East Afr J Ophthalmol. 2018 Jul-Dec;25(3-4):161-162. doi: 10.4103/meajo.MEAJO_263_17.

3.

Effect of Chloral Hydrate Sedation on Intraocular Pressure in a Pediatric Population.

Varadaraj V, Munoz B, Karaoui M, Collins ME, Aljasim LA, Al Naji E, Hamweyah K, Al Shamrani M, Craven ER, Friedman DS.

Am J Ophthalmol. 2018 Oct;194:126-133. doi: 10.1016/j.ajo.2018.07.023. Epub 2018 Jul 26.

PMID:
30055155
4.

Chloral Hydrate Administered by a Dedicated Sedation Service Can Be Used Safely and Effectively for Pediatric Ophthalmic Examination.

Karaoui M, Varadaraj V, Munoz B, Collins ME, Ali Aljasim L, Al Naji E, Hamweyah K, Al Shamrani M, Craven ER, Friedman DS.

Am J Ophthalmol. 2018 Aug;192:39-46. doi: 10.1016/j.ajo.2018.05.003. Epub 2018 May 26.

PMID:
29753853
5.

Overhanging-Dissecting Blebs: Immunohistochemical Characterization.

Al-Beshri AS, Edward DP, Haiti KA, Craven ER.

J Glaucoma. 2018 May;27(5):450-454. doi: 10.1097/IJG.0000000000000940.

PMID:
29595557
6.

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.

Lewis RA, Christie WC, Day DG, Craven ER, Walters T, Bejanian M, Lee SS, Goodkin ML, Zhang J, Whitcup SM, Robinson MR; Bimatoprost SR Study Group.

Am J Ophthalmol. 2017 Mar;175:137-147. doi: 10.1016/j.ajo.2016.11.020. Epub 2016 Dec 22.

7.

Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.

Al-Jumaian N, Malik R, Khandekar R, Al-Humaidan A, Al-Madany R, Al-Qahtani R, Altowairqi A, Al-Theeb A, Zaman B, Al-Djasim L, Craven ER, Edward DP.

Middle East Afr J Ophthalmol. 2016 Oct-Dec;23(4):296-301.

8.

Retrobulbar Injections for Blind Painful Eyes: A Comparative Study of Retrobulbar Alcohol Versus Chlorpromazine.

Galindo-Ferreiro A, Akaishi P, Cruz A, Khandekar R, Al Dosairi S, Dufaileej M, Al Salem A, Galvez-Ruiz A, Craven ER.

J Glaucoma. 2016 Nov;25(11):886-890.

PMID:
27814327
9.

Intraocular Pressure Outcomes Following Transscleral Diode Cyclophotocoagulation Using Long and Short Duration Burns.

Alzuhairy S, Albahlal A, Aljadaan I, Owaidhah O, Al Shahwan S, Craven ER, Mousa A, Edward DP.

J Glaucoma. 2016 Sep;25(9):e782-6. doi: 10.1097/IJG.0000000000000503.

PMID:
27513905
10.

Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts.

Vold S, Ahmed II, Craven ER, Mattox C, Stamper R, Packer M, Brown RH, Ianchulev T; CyPass Study Group.

Ophthalmology. 2016 Oct;123(10):2103-12. doi: 10.1016/j.ophtha.2016.06.032. Epub 2016 Aug 6.

PMID:
27506486
11.

Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.

Khor CC, Do T, Jia H, Nakano M, George R, Abu-Amero K, Duvesh R, Chen LJ, Li Z, Nongpiur ME, Perera SA, Qiao C, Wong HT, Sakai H, Barbosa de Melo M, Lee MC, Chan AS, Azhany Y, Dao TL, Ikeda Y, Perez-Grossmann RA, Zarnowski T, Day AC, Jonas JB, Tam PO, Tran TA, Ayub H, Akhtar F, Micheal S, Chew PT, Aljasim LA, Dada T, Luu TT, Awadalla MS, Kitnarong N, Wanichwecharungruang B, Aung YY, Mohamed-Noor J, Vijayan S, Sarangapani S, Husain R, Jap A, Baskaran M, Goh D, Su DH, Wang H, Yong VK, Yip LW, Trinh TB, Makornwattana M, Nguyen TT, Leuenberger EU, Park KH, Wiyogo WA, Kumar RS, Tello C, Kurimoto Y, Thapa SS, Pathanapitoon K, Salmon JF, Sohn YH, Fea A, Ozaki M, Lai JS, Tantisevi V, Khaing CC, Mizoguchi T, Nakano S, Kim CY, Tang G, Fan S, Wu R, Meng H, Nguyen TT, Tran TD, Ueno M, Martinez JM, Ramli N, Aung YM, Reyes RD, Vernon SA, Fang SK, Xie Z, Chen XY, Foo JN, Sim KS, Wong TT, Quek DT, Venkatesh R, Kavitha S, Krishnadas SR, Soumittra N, Shantha B, Lim BA, Ogle J, de Vasconcellos JP, Costa VP, Abe RY, de Souza BB, Sng CC, Aquino MC, Kosior-Jarecka E, Fong GB, Tamanaja VC, Fujita R, Jiang Y, Waseem N, Low S, Pham HN, Al-Shahwan S, Craven ER, Khan MI, Dada R, Mohanty K, Faiq MA, Hewitt AW, Burdon KP, Gan EH, Prutthipongsit A, Patthanathamrongkasem T, Catacutan MA, Felarca IR, Liao CS, Rusmayani E, Istiantoro VW, Consolandi G, Pignata G, Lavia C, Rojanapongpun P, Mangkornkanokpong L, Chansangpetch S, Chan JC, Choy BN, Shum JW, Than HM, Oo KT, Han AT, Yong VH, Ng XY, Goh SR, Chong YF, Hibberd ML, Seielstad M, Png E, Dunstan SJ, Chau NV, Bei J, Zeng YX, Karkey A, Basnyat B, Pasutto F, Paoli D, Frezzotti P, Wang JJ, Mitchell P, Fingert JH, Allingham RR, Hauser MA, Lim ST, Chew SH, Ebstein RP, Sakuntabhai A, Park KH, Ahn J, Boland G, Snippe H, Stead R, Quino R, Zaw SN, Lukasik U, Shetty R, Zahari M, Bae HW, Oo NL, Kubota T, Manassakorn A, Ho WL, Dallorto L, Hwang YH, Kiire CA, Kuroda M, Djamal ZE, Peregrino JI, Ghosh A, Jeoung JW, Hoan TS, Srisamran N, Sandragasu T, Set SH, Doan VH, Bhattacharya SS, Ho CL, Tan DT, Sihota R, Loon SC, Mori K, Kinoshita S, Hollander AI, Qamar R, Wang YX, Teo YY, Tai ES, Hartleben-Matkin C, Lozano-Giral D, Saw SM, Cheng CY, Zenteno JC, Pang CP, Bui HT, Hee O, Craig JE, Edward DP, Yonahara M, Neto JM, Guevara-Fujita ML, Xu L, Ritch R, Liza-Sharmini AT, Wong TY, Al-Obeidan S, Do NH, Sundaresan P, Tham CC, Foster PJ, Vijaya L, Tashiro K, Vithana EN, Wang N, Aung T.

Nat Genet. 2016 May;48(5):556-62. doi: 10.1038/ng.3540. Epub 2016 Apr 4.

PMID:
27064256
12.

Periocular skin hyperpigmentation in children treated with prostaglandin analogues.

Al-Zobidi M, Khandekar R, Craven ER, Hanafi S, Edward DP.

J AAPOS. 2015 Feb;19(1):49-53. doi: 10.1016/j.jaapos.2014.10.018.

PMID:
25727587
13.

Trabecular micro-bypass shunt (iStent®): basic science, clinical, and future).

Craven ER.

Middle East Afr J Ophthalmol. 2015 Jan-Mar;22(1):30-7. doi: 10.4103/0974-9233.148346. Review.

14.
15.

Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up.

Craven ER, Katz LJ, Wells JM, Giamporcaro JE; iStent Study Group.

J Cataract Refract Surg. 2012 Aug;38(8):1339-45. doi: 10.1016/j.jcrs.2012.03.025.

PMID:
22814041
16.

A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost.

Craven ER, Liu CC, Batoosingh A, Schiffman RM, Whitcup SM.

Clin Ophthalmol. 2010 Dec 6;4:1433-40. doi: 10.2147/OPTH.S14915.

17.

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.

Katz G, Springs CL, Craven ER, Montecchi-Palmer M.

Clin Ophthalmol. 2010 Nov 3;4:1253-61. doi: 10.2147/OPTH.S14113.

18.

Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.

Faulkner R, Sharif NA, Orr S, Sall K, Dubiner H, Whitson JT, Moster M, Craven ER, Curtis M, Pailliotet C, Martens K, Dahlin D.

J Ocul Pharmacol Ther. 2010 Apr;26(2):147-56. doi: 10.1089/jop.2009.0098.

PMID:
20307216
19.

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.

Frenkel RE, Noecker RJ, Craven ER.

Curr Med Res Opin. 2008 Apr;24(4):919-23. doi: 10.1185/030079908X273381 . Epub 2008 Feb 8.

PMID:
18267054
20.

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.

Katz LJ, Simmons ST, Craven ER.

Curr Med Res Opin. 2007 Dec;23(12):2971-83. Review.

PMID:
17949534
21.

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM, Whitcup SM.

Arch Ophthalmol. 2006 Sep;124(9):1230-8.

PMID:
16966616
23.

Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.

Craven ER, Walters TR, Williams R, Chou C, Cheetham JK, Schiffman R; Combigan Study Group.

J Ocul Pharmacol Ther. 2005 Aug;21(4):337-48.

PMID:
16117698
24.

Identification of a gene that causes primary open angle glaucoma.

Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC.

Science. 1997 Jan 31;275(5300):668-70.

25.

Risk management issues in the new managed care environment.

Bettman JW, Demorest BH, Craven ER.

Surv Ophthalmol. 1996 Nov-Dec;41(3):268-70. Review.

PMID:
8970242
26.

Risk management issues in glaucoma: diagnosis and treatment.

Craven ER.

Surv Ophthalmol. 1996 May-Jun;40(6):459-62.

PMID:
8724638
27.

Are UFOs dangerous?

Craven ER.

Ophthalmic Surg. 1988 Jul;19(7):465. No abstract available.

PMID:
3412755
28.

Applanation tonometer tip sterilization for adenovirus type 8.

Craven ER, Butler SL, McCulley JP, Luby JP.

Ophthalmology. 1987 Dec;94(12):1538-40.

PMID:
3431823
29.

Solving the mystery of aqueous humor.

Spaeth GL, Craven ER.

Ophthalmic Surg. 1987 Nov;18(11):791. No abstract available.

PMID:
3696682
30.

Sternal puncture.

Craven ER.

Br Med J. 1979 Oct 6;2(6194):867. No abstract available.

31.

Agranulocytosis four months after cimetidine therapy.

Craven ER, Whittington JM.

Lancet. 1977 Aug 6;2(8032):294-5. No abstract available.

PMID:
69896
32.

Consumption coagulopathy after intra-amniotic urea.

Grundy MF, Craven ER.

Br Med J. 1976 Sep 18;2(6037):677-8. No abstract available.

33.

An assessment of the value of the white cell count in the management of suspected acute appendicitis.

Bolton JP, Craven ER, Croft RJ, Menzies-Gow N.

Br J Surg. 1975 Nov;62(11):906-8.

PMID:
1191953
34.

Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.

Pounder RE, Craven ER, Henthorn JS, Bannatyne JM.

Gut. 1975 Mar;16(3):181-5.

Supplemental Content

Loading ...
Support Center